Business Description
Rapid7, Inc. provides cyber security solutions. The company offers a cloud-native insight platform that enables customers to create and manage analytics-driven cyber security risk management programs. Its platform includes InsightIDR, an incident detection and response solution; InsightCloudSec, a solution that integrates posture management, workload protection, infrastructure entitlements management, infrastructure-as-code security, and Kubernetes protection; InsightVM, a vulnerability risk management solution that is designed to provide a way to collect vulnerability data, prioritize risk, and automate remediation; InsightAppSec, which provides application security testing that analyzes web applications for security vulnerabilities; and InsightConnect, a security orchestration and automation response solution that is used by security professionals. The company's other products include DivvyCloud, a cloud security posture management solution; Nexpose, an on-premises version of company's vulnerability risk management solution; AppSpider, an on-premises version of company's application security testing solution; and Metasploit, a penetration testing software solution, as well as professional services. It offers its products through term or perpetual software licenses, cloud-based subscriptions, and managed services. The company serves customers in a range of industries, including technology, energy, financial services, healthcare and life sciences, manufacturing, media and entertainment, retail, education, real estate, transportation, government, and professional services industries through sales teams, and indirect channel partner relationships, as well as directly in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2000 and is headquartered in Boston, Massachusetts.
Business History
Generated: Apr 23, 2026 10:00amPrice Overview
Last updated: May 24, 2026 11:55am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 0.36
Total Equity: $154.73M
Shares: 65,002,000
Total Debt: $968.37M
Cash: $246.66M
EBITDA: $86.05M
Total Debt: $968.37M
Cash: $246.66M
Revenue: $859.79M
Revenue: $859.79M
Revenue: $859.79M
Total Equity: $154.73M
Tax Rate: 22.5%
Equity: $154.73M
Total Debt: $968.37M
Cash: $246.66M
Current Liabilities: $575.37M
Long-Term Debt: $952.19M
Total Debt: $968.37M
Total Equity: $154.73M
Shares: 65,002,000
Shares: 65,002,000
CapEx: -$7.60M
Shares: 65,002,000
Stock Price: $7.27
Net Income: $23.38M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: May 24, 2026 11:22am (32m ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $535.4M | $685.1M | $777.7M | $844.0M | $859.8M |
| Cost of Revenue | $168.9M | $214.3M | $231.7M | $251.0M | $255.0M |
| Gross Profit | $366.5M | $470.7M | $546.0M | $593.0M | $604.8M |
| Operating Expenses | $486.5M | $582.3M | $626.7M | $557.9M | $593.2M |
| Operating Income | -$120.1M | -$111.6M | -$80.7M | $35.0M | $11.6M |
| Net Income | -$146.3M | -$124.7M | -$149.3M | $25.5M | $23.4M |
| EBITDA | -$88.1M | -$70.3M | -$39.1M | $97.3M | $86.1M |
| EPS | $-2.65 | $-2.13 | $-2.46 | $0.41 | $0.36 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: May 23, 2026 4:09am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $164.6M | $207.3M | $213.6M | $334.7M | $246.7M |
| Total Current Assets | $432.7M | $510.3M | $634.5M | $786.1M | $688.9M |
| Total Assets | $1.3B | $1.4B | $1.5B | $1.7B | $1.7B |
| Current Liabilities | $468.7M | $531.3M | $569.8M | $630.2M | $575.4M |
| Long-Term Debt | $812.1M | $815.9M | $930.0M | $888.4M | $952.2M |
| Total Liabilities | $1.4B | $1.5B | $1.6B | $1.6B | $1.6B |
| Total Equity | -$126.0M | -$120.1M | -$118.2M | $17.7M | $154.7M |
| Retained Earnings | -$736.0M | -$860.7M | -$1.0B | -$988.0M | -$964.7M |
Cash Flow (Annual)
Last updated: May 24, 2026 11:22am (32m ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $53.9M | $78.2M | $104.3M | $171.7M | $152.1M |
| Capital Expenditure | -$9.0M | -$20.4M | -$4.4M | -$3.4M | -$7.6M |
| Free Cash Flow | $44.9M | $57.8M | $99.9M | $168.2M | $144.5M |
| Acquisitions (net) | -$358.4M | $-300,000 | -$34.8M | -$37.3M | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$9.0M | $42.7M | $6.3M | $128.5M | -$95.4M |
Analyst Estimates (Annual)
Last updated: May 24, 2026 11:22am (32m ago)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$838.6M $838.1M – $839.3M
|
$836.8M $807.7M – $857.7M
|
$846.6M $844.7M – $848.6M
|
$904.0M $887.4M – $919.8M
|
| EBITDA |
$316.2M $316.0M – $316.5M
|
$315.6M $304.6M – $323.4M
|
$319.3M $318.5M – $320.0M
|
$340.9M $334.6M – $346.8M
|
| Net Income |
$99.8M $96.6M – $103.1M
|
$99.3M $85.9M – $112.6M
|
$107.2M $95.8M – $118.7M
|
$128.1M $125.0M – $131.0M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: May 24, 2026 11:22am (32m ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +28.0% | +13.5% | +8.5% | +1.9% |
| Gross Profit Growth | +28.5% | +16.0% | +8.6% | +2.0% |
| Operating Income Growth | +7.0% | +27.7% | +143.4% | -67.0% |
| Net Income Growth | +14.8% | -19.7% | +117.1% | -8.4% |
| EBITDA Growth | +20.2% | +44.3% | +348.6% | -11.6% |
Insider Trading (Recent)
Last updated: May 24, 2026 11:22am (32m ago)| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-15 | Murphy Scott M | F-InKind | 1,059.00 | $6.50 | $6,884 |
| 2026-05-15 | Thomas Corey E. | F-InKind | 5,357.00 | $6.50 | $34,821 |
| 2026-02-17 | Murphy Scott M | A-Award | 20,000.00 | $0.00 | $0 |
| 2026-04-22 | Murphy Scott M | S-Sale | 827.00 | $6.35 | $5,251 |
| 2026-04-15 | Murphy Scott M | F-InKind | 344.00 | $5.76 | $1,981 |
| 2026-03-31 | Thomas Corey E. | A-Award | 1,125,000.00 | $0.00 | $0 |
| 2026-03-31 | Brown Rafeal E. | A-Award | 275,000.00 | $0.00 | $0 |
| 2026-02-23 | Murphy Scott M | S-Sale | 1,267.00 | $6.51 | $8,248 |
| 2026-02-15 | Thomas Corey E. | A-Award | 64,667.00 | $0.00 | $0 |
| 2026-02-15 | Thomas Corey E. | F-InKind | 22,328.00 | $7.18 | $160,315 |
| 2026-02-15 | Murphy Scott M | F-InKind | 673.00 | $7.18 | $4,832 |
| 2026-01-22 | Murphy Scott M | S-Sale | 764.00 | $12.70 | $9,703 |
| 2026-01-15 | Murphy Scott M | F-InKind | 406.00 | $13.30 | $5,400 |
| 2025-12-18 | Thomas Corey E. | M-Exempt | 200,000.00 | $12.98 | $2.6M |
| 2025-12-18 | Thomas Corey E. | F-InKind | 182,321.00 | $15.66 | $2.9M |
| 2025-12-18 | Thomas Corey E. | M-Exempt | 200,000.00 | $12.98 | $2.6M |
| 2025-11-28 | JANA Partners Management, LP | P-Purchase | 41,545.00 | $15.71 | $652,672 |
| 2025-12-01 | Brown Rafeal E. | A-Award | 466,999.00 | $0.00 | $0 |
| 2025-12-01 | Brown Rafeal E. | 0.00 | $0.00 | $0 | |
| 2025-11-26 | Schodorf Thomas E | P-Purchase | 6,300.00 | $15.70 | $98,910 |
Narrative Economics
Delvantic AI Findings
Looking at the raw numbers first: Rapid7 is doing $859.8M in 2025 revenue, up from $844.0M — that's 1.9% YoY, effectively stall speed. The quarterly sequence ($205M → $208M → $215M → $216M → $210M → $214M → $218M → $217M) shows revenue has flatlined around $215M for four quarters running. This isn't a growth company anymore; it's a utility. But the cash generation is real and improving: $144.5M FCF on $152.1M OCF with trivial capex, and net income turned positive across all four 2025 quarters ($23.4M full year). Gross margin is 70%, which is respectable but light for enterprise SaaS (best-in-class is 75-80%). Operating margin of 1.35% GAAP is thin — the profitability story is FCF, not GAAP earnings, because of heavy SBC add-backs (visible in the award grants of 1.1M + 275K + 467K shares — material dilution on a 65M share count).
Now the models. The Valuation Synthesis is working from numbers that don't match what I'm seeing. It cites "$878M debt with 1.1x interest coverage," "0.4x P/S," and "$19M insider buying" — but the tile shows P/S of 1.14x (not 0.4x), debt as "—" (not disclosed, so the $878M figure is unsourced in this file), and cash of $246.7M. Market cap is $380M; even if debt really is ~$878M, EV/revenue would be ~1.5x, not the 2.05x shown either. Something is inconsistent. The ev_to_ebitda of 13.5x and P/E of 16.4x TTM do NOT suggest a company priced for liquidation — they suggest a company priced roughly in line with a no-growth mature software business. The Synthesis narrative of "distressed asset pricing" appears to be overdramatic or based on a different data snapshot (possibly when the stock was lower). At $5.84 and 1.1x sales, RPD is cheap but not priced for death.
The contrarian case against the bullish "disconnected from fundamentals" read: revenue growth of 1.9% in a cybersecurity market growing 12-15% means Rapid7 is LOSING share every quarter. That's not a stable melting ice cube — that's accelerating relative decline in a category where scale and platform breadth are winning (CrowdStrike, Palo Alto, Wiz, SentinelOne all growing 20%+). The 70% gross margin is 5-10 points below peers, suggesting pricing pressure or unfavorable mix. The SBC-heavy compensation (millions of shares being awarded) means FCF overstates owner earnings by probably $60-80M annually — real owner FCF is closer to $70-90M, and on $380M market cap + whatever net debt exists, that's not screamingly cheap if growth is zero-to-negative. The insider purchases (50K, 150K, 41K, 6K shares in late November 2025) are real but modest in dollar terms at these prices — maybe $1-2M total, not the "$19M" the Synthesis cites.
Where the data is thin: total debt and total equity are both blank in the balance sheet section, which is the single most important variable for this thesis. If RPD carries the convertible notes I vaguely recall (~$600M range), interest coverage and refinancing risk matter enormously. The Synthesis treats debt as central but the file doesn't actually show it. The insider list also has unnamed filers ("?") which makes it impossible to distinguish CEO conviction buying from director box-checking. The TTM metrics are from a different window than the annual tile, flagged appropriately.
My read: the prior models are directionally right that RPD is cheap for a profitable SaaS business, but the Synthesis's "disconnected from fundamentals / acquisition at premium likely" framing is too aggressive. This is a no-growth, share-losing, SBC-diluting cybersecurity vendor with a possibly stressed balance sheet, generating real but overstated cash. At 1.1x sales and ~16x earnings, it's priced as a dying-but-not-dead business — which is approximately what the numbers say it is. M&A optionality exists but isn't a layup; strategic acquirers have been buying faster-growing assets (Wiz at $32B by Google, etc.) not decelerating legacy vendors. I dissent from the "compelling risk-adjusted returns" framing and land closer to "cheap but deservedly so, with binary M&A optionality." Fair value in a standalone case is maybe $7-9 (1.3-1.6x sales, ~20x owner FCF); in an acquisition case $10-12. Current $5.84 offers modest upside with real downside if debt refinancing sours.
GPT Critique
Upon reviewing Rapid7's financial data, what stands out most to me is the stark contrast between its modest revenue growth and its relatively strong free cash flow generation. The revenue growth is indeed anemic at 1.9% YoY for 2025, stagnating around $215M per quarter. However, the company has managed to turn a profit with net income of $23.4M for the year and a free cash flow of $144.5M, which is impressive given its past losses. The gross margin of 70% is decent, though not exceptional for the industry, indicating some pricing or competitive pressures. Despite these pressures, the operating cash flow of $152.1M and minimal capex suggest that Rapid7 is generating substantial cash, which could be a lifeline in a consolidating market.
I disagree with Opus's assertion that the company's valuation metrics imply pricing for liquidation. The P/E ratio of 16.4x and ev_to_ebitda of 13.5x do not suggest a distressed valuation. These metrics indicate a mature software company with no growth rather than a company on the brink of failure. Opus's claim that Rapid7 is priced for death is overly pessimistic. The discrepancy in the P/S ratio (1.14x shown in the data vs. 0.4x claimed by Opus) further undermines the notion that the market has given up entirely on Rapid7's potential.
However, I concur with Opus's assessment that Rapid7 is losing market share, as evidenced by its growth lagging behind the broader cybersecurity market, which is expanding at 12-15%. This relative decline poses a significant challenge, especially given the high competitive pressures from larger platforms like CrowdStrike and Palo Alto. Opus rightly points out that the company's heavy reliance on stock-based compensation dilutes actual owner earnings, making the FCF appear more robust than it truly is.
A careful skeptic might argue that both my view and Opus's overlook the potential for strategic restructuring or divestitures that could unlock value. They might also highlight that the absence of specific debt figures in the data introduces significant uncertainty regarding Rapid7's financial health and the potential impact of refinancing risks. Furthermore, the insider buying, while modest, could indicate insider confidence in the company's strategic direction, suggesting that management may have a plan to address these challenges.
Opus Reconsideration
PART 1 — Public response:
The second reviewer and I largely converge, which makes this a short response. They accept the core of my pushback — that the prior Valuation Synthesis was working from numbers inconsistent with the tile (0.4x P/S vs. actual 1.14x, a $878M debt figure that doesn't appear in the data, $19M insider buying vs. the ~$1-2M actually visible) and that 16.4x TTM P/E and 13.5x EV/EBITDA are not liquidation multiples. We land at the same fair value range ($7-9) and the same posture: cheap but deservedly so, with M&A as optionality rather than thesis.
Where the reviewer pushes back mildly — framing Rapid7's $144.5M FCF and $152.1M OCF as "impressive" and "a lifeline" — I'd hold my line. Gross FCF of $144.5M on a company issuing roughly 1.9M shares in awards in early 2026 alone (1.125M + 275K + 467K + 64K grants visible in the insider log) means dilution is eating a material slice of that cash flow. At ~$6 per share that's $10M+ of economic cost per award tranche, and the pattern repeats. Real owner FCF is closer to $70-90M once you haircut for SBC, which on a $380M market cap is ~4-5x — cheap, but not the eye-popping 2.6x headline FCF yield the gross number implies. The reviewer acknowledges this point later but doesn't carry it into their assessment of cash generation strength.
The reviewer's closing observation about the skeptic's view — that missing debt figures introduce real uncertainty — is the single most important unresolved variable and I should have weighted it more heavily in my original. If Rapid7's convertibles (which I referenced from memory) are genuinely ~$600M maturing in the next few years, the refinancing math at current rates materially changes the equity story. The tile showing "Total debt: —" is a data gap, not an absence of debt, and I treated it a bit too lightly. That's a legitimate gap-filling exercise for the next pass.
On the substantive business read — 1.9% growth in a 12-15% market, 70% gross margin running 5-10 points below peers, SBC dilution, share loss to CrowdStrike/Palo Alto/Wiz — the reviewer and I agree. Nothing in their critique moves me off the $7-9 standalone range or the "speculative small position for M&A optionality" posture. The insider buying is real but modest in dollars and doesn't constitute a thesis by itself.